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Incidental finding of lymphoma after septoplasty
Edward C. Kuan, M.D., M.B.A.,1 Bobby A. Tajudeen, M.D.,1 Sunita M. Bhuta, M.D.,2
Miguel Fernando Palma Diaz, M.D.,2 Paul A. Kedeshian, M.D.,1 and Jeffrey D. Suh, M.D.1
ABSTRACT
Introduction: Septoplasty, or surgical correction of the deviated septum, is an elective, routinely performed rhinologic
procedure to address nasal airway obstruction. In many cases, resected septal cartilage and bone fragments are sent for
pathologic review, although there is no consensus on this practice. We reported two cases of incidentally diagnosed lymphoma
after elective septoplasty and discussed clinical presentation, diagnosis, and management.
Methods: Retrospective chart review of two patients who underwent septoplasty at a tertiary academic medical center and
found to have incidental lymphoma based on histopathology.
Results: Two patients who underwent septoplasty had an incidental diagnosis of lymphoma on pathologic analysis. One
patient was noted to have an S-shaped septal deviation that produced bilateral nasal obstruction. She underwent a difficult
septoplasty, in which the mucoperichondrial flap was firmly adherent to the underlying septum and bone. Final pathology
demonstrated diffuse large B-cell lymphoma. She was treated with chemoradiation and remained free of disease at 59 months.
The other patient had a history of nasal trauma, which produced left septal deviation. He underwent an uncomplicated
septoplasty, with pathology that demonstrated low-grade B-cell lymphoma. Because there was no evidence of active disease, the
decision was made to not treat and to observe the patient clinically.
Conclusions: This is the first reported series of septal lymphoma incidentally diagnosed on routine septoplasty. Although
histopathologic review of specimens from routine nasal and sinus surgery is not routinely performed, this report highlighted
the importance of this process, on a case-by-case basis, in detecting unexpected malignancies that otherwise were clinically
silent.
(Allergy Rhinol 7:e90–e95, 2016; doi: 10.2500/ar.2016.7.0153)
Septoplasty, or surgical correction of the deviatednasal septum, is an elective, routinely performed
otolaryngologic procedure indicated for improvement
of anatomic nasal airway obstruction. It is one of the
most commonly performed otolaryngologic surgeries
and the most commonly performed nasal surgery, with
an estimated 260,000 septoplasties performed per
year.1 Due to the sheer number of pathologic speci-
mens yielded from this seemingly benign procedure
alone, several studies have examined the utility and
practicality of routine histopathologic analysis of nasal
and sinus surgery. Romashko and Stankiewicz2 re-
ported a retrospective review of 868 endoscopic sinus
surgical specimens, in which only two specimens
(0.23%) harbored occult malignancies. Another study,
which involved 1944 endoscopic sinus surgical cases in
which no unexpected malignancy samples were found,
indicated that, unless there is preoperative clinical sus-
picion for malignancy, routine histopathologic review
of sinonasal surgical specimens is generally not indi-
cated.3 Daniero et al.4 reported a large series on routine
analysis of surgical specimens from septal and inferior
turbinate surgery; none of the 1194 septal and 714
inferior turbinate samples were found to have unan-
ticipated diagnoses. Yet, despite having overwhelm-
ingly unlikely odds of detecting an occult malignancy,
actual pathologic confirmation of such a diagnosis
leads to timely workup and treatment and thus is
potentially lifesaving.
Although there has been some interest in histopatho-
logic detection of occult malignancies in sinonasal sur-
gery, no previous reports identified incidental malig-
nancies during septal surgery. In this study, we
reported two cases of incidentally diagnosed lym-
phoma after elective septoplasty, both of which were
clinically silent, and we discussed clinical presentation,
diagnosis, management, and treatment outcomes.
METHODS
This study was approved by the institutional review
board of the University of California, Los Angeles. A
comprehensive review of the institutional pathology
data base at a tertiary academic medical center was
conducted and identified, between January 1, 2001,
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and December 31, 2014, 329 septoplasty specimens that
were sent for histopathologic review. During the same
time period, a larger, indeterminate number of septo-
plasties were performed, although it was estimated to
be 150–200 cases/y. The choice of submitting for his-
topathologic review was based on the primary sur-
geon’s preference. We retrospectively reviewed the re-
cords of two patients who underwent elective
septoplasty and who were both later found to have an
incidental diagnosis of septal lymphoma. Analysis was
limited to only septal contents (cartilage and bone)
because mucosa was preserved during each procedure.
For both cases, endoscopic septoplasty was the tech-
nique used. A hemitransfixion incision is made, and an
ipsilateral mucoperichondrial flap is elevated. After
leaving an adequate caudal and dorsal strut, the quad-
rangular cartilage is transected and the contralateral
mucoperichondrial flap is elevated. Deviated cartilage
and bone is resected and sent for histopathologic anal-
ysis. Correction of deviation is confirmed via endonasal
examination. Absorbable sutures are then used to
loosely close the hemitransfixion incision, and a quilt-
ing stitch is occasionally used to reappose the bilateral
mucoperichondrial flaps.
RESULTS
The clinical history, presentation, management, and
postoperative course of each patient are presented be-
low.
Case 1
A 46-year-old female patient presented to the head
and neck surgery clinic for bilateral nasal airway ob-
struction and congestion. She also reported occasional
facial pressure and headache, which was worse on the
left side. She had undergone computed tomography of
the sinuses, which demonstrated an “S”-shaped nasal
septum, without evidence of inflammatory sinus dis-
ease. Her medical and surgical histories were signifi-
cant for Hashimoto thyroiditis for which she had un-
dergone thyroidectomy 6 years earlier. She also had
chronic microcytic hypochromic anemia for which no
source of occult hemorrhage was found on workup
(i.e., endoscopy). Preoperative laboratory studies dem-
onstrated anemia (hemoglobin level, 10.5 g/dL) and
a mildly elevated erythrocyte sedimentation rate
(48 mm/hour) but were otherwise within normal lim-
its. Physical examination confirmed the septal devia-
tion, and the patient elected to undergo septoplasty.
There were no septal mucosal abnormalities seen on
nasal endoscopy. During the septoplasty, despite hav-
ing had no previous nasal surgery or inflammatory
disease and having normal-appearing mucosa, the sub-
mucosal tissue was extremely adherent to the under-
lying cartilage and bone, which made elevation of the
bilateral mucoperichondrial flaps difficult. Neverthe-
less, the deviated cartilage and bone were successfully
resected, and the patient tolerated the procedure well,
without complications.
The final pathologic analysis of the septal specimen
at 1 week after surgery showed a diffuse infiltrate of
atypical, moderate-to-large lymphoid cells within the
septal bone. Immunohistochemistry stains were posi-
tive for CD20, CD10, and BCL6 and negative for
MUM-1 and BCL2. These findings were consistent
with a diagnosis of diffuse large B-cell lymphoma
(Fig. 1). The patient was referred to the hematology/
oncology and radiation oncology services for further
workup. She underwent a bone marrow biopsy; results
were normocellular and did not demonstrate dissemi-
nated disease. A whole-body positron emission tomog-
raphy–computed tomography confirmed the absence of
distant metastases. Chromosomal analysis was normal
(46, XX). These findings were consistent with stage IE
disease, and the patient was subsequently treated with
chemotherapy 1 month after surgery, followed by con-
solidative radiation therapy (3600 cGy). She tolerated the
treatment well and had no clinical or radiographic evi-
dence of recurrent disease at 59 months after surgery.
Case 2
A 60-year-old male patient presented to the rhinol-
ogy clinic with severe left-sided nasal airway obstruc-
tion after sustaining nasal trauma years earlier. His
medical and surgical histories were otherwise unre-
markable. Nasal endoscopy demonstrated a severe left
septal deviation with the septum touching the left in-
ferior turbinate; the right nasal cavity contained no
anatomic deviation. No mucosal abnormalities were
seen. Preoperative laboratory study results were all
within normal limits. The patient decided to proceed
with elective septoplasty. The septoplasty procedure
was unremarkable, and he tolerated the procedure
well, without complications.
The final pathologic analysis of the septal bone at 1
week after surgery showed marrow elements, with a
sparse, primarily interstitial, atypical lymphocytosis
composed of small B cells that stain positive for CD20
and BCL2 and negative for CD5, CD10, BCL1, and
CD23 (Fig. 2), which indicated a diagnosis of a low-
grade B-cell lymphoproliferative disorder, likely follic-
ular lymphoma. He was referred to the hematology/
oncology service for further evaluation. A whole-body
positron emission tomography–computed tomogra-
phy did not identify any distant disease. Due to the
patient’s lack of symptoms and negative laboratory
and radiologic workup, he will be monitored closely
with regular visits to determine any changes.
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DISCUSSION
Septoplasty is the most commonly performed elec-
tive nasal procedure. Because the primary indication of
the procedure is for the relief of anatomic nasal airway
obstruction, many otolaryngologists generally do not
send the extracted cartilage and bone fragments for
histopathologic analysis. Furthermore, scarring be-
tween the tissue planes is not unusual, especially if
patients have a history of nasal trauma or previous
nasal surgery. Although there is ample evidence that
the rate of occult malignancy in nasal and sinus sur-
gery is low, an actual diagnosis of a malignancy is
extremely clinically significant.
In light of the current health care socioeconomic
climate, there has been a strong push toward the con-
scious practice of cost-effective, systems-based medi-
cine. The role of routine histopathologic analysis of
surgical specimens from elective procedures has been
Figure 1. Septal contents from
the patient in case 1, demonstrat-
ing a diffuse infiltrate of atypical
moderate-to-large lymphocytes on
hematoxylin and eosin staining
(A, B), which further stained pos-
itive for CD20 (C), CD10 (D), and
BCL6 (E), and confirmed the diag-
nosis of diffuse large B-cell lym-
phoma. (F) Computed tomography
of sinuses demonstrates left septal
deviation with no visible abnor-
malities seen on the scan. All im-
ages are 10  magnification.
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examined frequently across specialties. For instance,
there is no consensus on this topic within the general
surgery literature, in which some investigators support
pathologic review of all specimens5,6; other investiga-
tors encourage only analyzing specimens if the macro-
scopic tissue appearance or clinical history is consistent
with more concerning underlying conditions7; whereas
other investigators deem the incidence of malignancy
to be so low that routine pathologic review is unnec-
essary or even “useless.”8,9 In addition to the study by
Daniero et al.,4 Haffey et al.10 further examined the
clinical and financial value of routine review of septal
surgical specimens. Of 516 septoplasties performed,
303 specimens were sent for pathologic analysis, with
no unexpected diagnoses.10
The investigators further found that pathology-re-
lated charges, valued at $255 per specimen, accounted
for 2% of the total charges per procedure, which
accumulated to $130,000 over the course of 2 years.10
Although a considerable sum, the costs associated with
treating aggressive non-Hodgkin lymphoma, such as
diffuse large B-cell lymphoma, at an advanced stage
(i.e., from late or missed presentation) are astronomical
in comparison, estimated to be $9000 per month at
the palliation stage.11 In addition, to a lesser extent,
errors in diagnosis, such as missed diagnoses, are the
second most common of rhinology-related litigation.12
This, taken together with the improved outcomes with
early intervention and the negative impact on quality
of life with a late diagnosis, prompts a reexamination
of the true value of histopathologic analysis in elective
nasal surgery. Nevertheless, based on the literature
and our own institution’s experience, routine histo-
pathologic review of all specimens in elective nasal
surgery, indeed, is not cost effective and should be
considered on a case-by-case basis.
Diffuse large B-cell (non-Hodgkin) lymphoma is the
most common type of sinonasal lymphoma.13 In the
largest review of non-Hodgkin lymphoma of the sino-
nasal cavity, Abbondanzo andWenig14 found that low-
grade lesions tend to present with nasal obstruction
(the most common overall presentation), whereas
high-grade lesions present with nonhealing ulcers,
pain, facial swelling, epistaxis, or even cranial nerve
palsies.14 Furthermore, T-cell lymphomas were more
likely to be midline (i.e., involving the nasal septum)
and to behave aggressively, with significant local tissue
destruction.14 The fact that both cases were B-cell pre-
dominant malignancies may explain their relatively
more indolent and clinically silent course. Although
reported in previous series, in both cases, there were no
classic harbingers of lymphoproliferative disorders,
such as constitutional symptoms (fevers, chills, weight
loss, night sweats) or generalized lymphadenopathy.15
Also, given the localized nature of each case, it was
unlikely for disease to be suspected based on labora-
tory or imaging studies. However, it is also conceivable
that, despite the absence of classic signs and symptoms
of lymphoproliferative disorders, the defining clinical
manifestation of septal lymphomas is actually ana-
tomic nasal obstruction due to septal deviation, and
that this complaint may also prompt early consultation
and lead to elective surgery, which possibly facilitates
diagnosis.
A well-accepted canon of sinonasal surgery is that a
unilateral nasal mass should carry a higher suspicion
for neoplasm. Numerous studies have attempted to
describe the incidence of occult tumors in routine nasal
surgery, with nasal polyposis samples having been the
most extensively studied. Yaman et al.16 found that,
although 85 patients with bilateral nasal polyposis had
no neoplastic process diagnosed on histology, 6 of 32
patients (19%) with unilateral nasal “polyposis” were
found to have neoplasms, which is similar to the re-
sults in the study by Arslan et al.,17 in which 7 of 54
patients with unilateral nasal “polyposis” were diag-
nosed with neoplasms, whereas none of the 197 pa-
tients with bilateral polyposis were diagnosed with
neoplasms. However, larger series, such as those re-
ported by Garavello and Gaini, 18,19 indicate that the
incidence of occult neoplasm is actually much less, on
the order of 1%. Neither case in this series had any
Figure 2. Septal contents from the
patient in case 2, demonstrating
marrow elements with a sparse, pri-
marily interstitial atypical lympho-
cytosis composed of small B cells on
hematoxylin and eosin staining (A),
which further stain positive for
CD20 (B) and BCL2 (C), and neg-
ative for CD5, CD10, BCL1, and
CD23, indicating a diagnosis of a
low-grade B-cell lymphoprolifera-
tive disorder. All images are 10 
magnification.
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mass or mucosal lesion suspicious for malignancy,
with the surgical indication for both cases being ana-
tomic nasal obstruction, and the neoplastic process, in
actuality, was embedded with the bony septal tissues.
The mainstay of treatment for sinonasal lymphoma
is chemotherapy and/or radiation, with surgery only
playing a diagnostic role. For patients with stage 1E
disease (defined as involvement of one organ or extra-
nodal area), there were reports that overall 5-year sur-
vival ranges from 67 to 75%.20–22 Left undiscovered
and untreated, the natural progression of B-cell lym-
phomas of the sinonasal tract is aggressive local exten-
sion, with the potential for multiorgan involvement.
Based on the findings of the International Non-Hodg-
kin Lymphoma Prognostic Factors Project, the Interna-
tional Prognostic Index was developed for the prog-
nostication of non-Hodgkin lymphoma, including
diffuse large B-cell lymphoma.23 For the patient in case
1, she would have had an International Prognostic
Index of 0 (low risk), and the standard of care for the
treatment of limited stage diffuse large B-cell lym-
phoma is chemoradiation,24 with observation that
demonstrated decreased disease-free survival in one
study.25 For these reasons, the patient in case 1 under-
went a more aggressive treatment regimen and did not
elect for observation. However, the patient in case 2
had a low-grade B-cell lymphoproliferative disorder,
likely a follicular lymphoma, which is associated with
a more favorable diagnosis. In fact, limited-stage fol-
licular lymphomas may actually be observed because
many such patients do not require additional treat-
ment.26,27
Based on the Lugano guidelines,28 posttreatment
surveillance for patients with low-grade sinonasal lym-
phoma involves regular clinical visits with their oncol-
ogists every 3 months for the first 2 years, followed by
every 6 months for the subsequent 3 years, and annu-
ally thereafter. Patients should also be counseled on
considering follow-up visits with their rhinologist at
concurrent intervals to endoscopically evaluate the bi-
opsy site for initial proper healing and local recurrence.
CONCLUSION
To our knowledge, this is the first reported series of
septal lymphoma incidentally diagnosed on septo-
plasty. Although histopathologic review of surgical
specimens from routine nasal and sinus surgery is not
always performed (and oftentimes, not encouraged),
this report highlighted the importance of this process
in detecting unexpected malignancies that otherwise
were clinically silent. At this point, given the rarity of
such diagnoses in light of increased health care costs,
there are no defining clinical or intraoperative charac-
teristics that may prompt the surgeon to elect histo-
pathologic review of septoplasty specimens that con-
tain lymphoproliferative disorders but rather must be
considered on a case-by-case basis.
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